3B BlackBio
Bhopal, India· Est.
India‑based provider of comprehensive PCR‑based molecular diagnostic kits for oncology, infectious disease and genetics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based provider of comprehensive PCR‑based molecular diagnostic kits for oncology, infectious disease and genetics.
OncologyInfectious DiseasesGenetics & Genomics
Technology Platform
PCR‑based molecular diagnostics (qPCR, real‑time PCR) combined with NGS panels and rapid antigen immunoassays, all validated against WHO/CDC standards.
Opportunities
Expanding molecular testing in emerging markets and leveraging its NGS panels to capture oncology and infectious disease diagnostics growth.
Risk Factors
Regulatory hurdles in new geographies, intense competition from global diagnostic giants, and reliance on third‑party PCR instrument compatibility.
Competitive Landscape
Competes with companies like Cepheid, BioMérieux, and QIAGEN; differentiates through cost‑effective, open‑system kits and a broad, region‑specific product portfolio.